| |
Number or median |
| CD133: positive/negative |
32/14 |
| Median age (range) |
59.1 (28-80) |
| Sex: male/female |
29/17 |
| PS: 0/1/2 |
34/12/0 |
| Primary site: colon/rectum |
30/16 |
| Status of primary tumor: Resected/Unresected |
35/11 |
| Sites of metastasis: +/- |
|
| Liver |
38/8 |
| Lung |
33/13 |
| Bone |
6/40 |
| Peritoneum |
8/38 |
| Lymph node |
13/33 |
| Local recurrence |
3/43 |
| Prior treatment |
|
| 5FU |
46 |
| Irinotecan |
30 |
| Oxaliplatin |
44 |
| Bevacizumab |
22 |
| No. of previous chemotherapy: one/two |
17/29 |
| Treatment: |
|
| FOLFIRI with Cmab/ PT11 with Cmab/Cmab alone |
15/21/10 |
| CA19-9: >37.5/≤37.5 |
23/23 |
| CEA: >5/≤5 |
38/8 |
PS: performance status; Cmab: cetuximab. |
